Advances in Collaborative Practice for Patients With Head and Neck Cancers

Head and neck cancer care is complex, and there are limited treatment options; over the past decade only one new therapy received FDA approval. However, as in other tumor types, the landscape is changing with the recent emergence of newer targeted therapies and immunotherapies.

Detalles Bibliográficos
Autores principales: Haddad, Robert, Glass, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003755/
https://www.ncbi.nlm.nih.gov/pubmed/29928549
Descripción
Sumario:Head and neck cancer care is complex, and there are limited treatment options; over the past decade only one new therapy received FDA approval. However, as in other tumor types, the landscape is changing with the recent emergence of newer targeted therapies and immunotherapies.

Ejemplares similares